Published in Clin Risk on March 01, 2012
Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J (2008) 12.31
Impracticability of informed consent in the Registry of the Canadian Stroke Network. N Engl J Med (2004) 9.85
Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet (1960) 7.96
Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 5.96
Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry. Circulation (2008) 2.00
Emergency Department diagnosis of pulmonary embolism is associated with significantly reduced mortality: a linked data population study. Emerg Med Australas (2009) 1.54
Observer variation in the clinical assessment of stroke. Age Ageing (1976) 1.31
Ethical issues in implementation research: a discussion of the problems in achieving informed consent. Implement Sci (2008) 1.12
Regional variation in survival of people with cerebral palsy in the United Kingdom. Pediatrics (2005) 0.87
Cerebral palsy life expectancy. Clin Perinatol (2006) 0.86
Intrauterine growth and survival in cerebral palsy. Arch Dis Child Fetal Neonatal Ed (2007) 0.83
Meta-analysis of drug-related deaths soon after release from prison. Addiction (2010) 3.96
Aggregate data meta-analysis with time-to-event outcomes. Stat Med (2002) 3.63
Maximising response to postal questionnaires--a systematic review of randomised trials in health research. BMC Med Res Methodol (2006) 3.59
Modeling the current and future disease burden of hepatitis C among injection drug users in Scotland. Hepatology (2005) 1.91
A record-linkage study of drug-related death and suicide after hospital discharge among drug-treatment clients in Scotland, 1996-2006. Addiction (2012) 1.88
Incomplete contingency tables with censored cells with application to estimating the number of people who inject drugs in Scotland. Stat Med (2013) 1.74
Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol (2005) 1.53
Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia (2002) 1.53
Buried data and the UK Healthcare Commission's legacy. Lancet (2009) 1.39
Take-home emergency naloxone to prevent heroin overdose deaths after prison release: rationale and practicalities for the N-ALIVE randomized trial. J Urban Health (2013) 1.34
The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS One (2013) 1.32
Injecting drug users in Scotland, 2006: Listing, number, demography, and opiate-related death-rates. Addict Res Theory (2012) 1.29
Response and non-response to postal questionnaire follow-up in a clinical trial--a qualitative study of the patient's perspective. J Eval Clin Pract (2007) 1.22
Association of self-reported alcohol use and hospitalization for an alcohol-related cause in Scotland: a record-linkage study of 23,183 individuals. Addiction (2009) 1.18
Estimating current injectors in Scotland and their drug-related death rate by sex, region and age-group via Bayesian capture--recapture methods. Stat Methods Med Res (2008) 1.12
Prevalence of visual field loss following exposure to vigabatrin therapy: a systematic review. Epilepsia (2010) 1.09
Mortality of those who attended drug services in Scotland 1996-2006: record-linkage study. Int J Drug Policy (2011) 1.05
Long-term survival for a cohort of adults with cerebral palsy. Dev Med Child Neurol (2006) 1.04
A population-based record linkage study of mortality in hepatitis C-diagnosed persons with or without HIV coinfection in Scotland. Stat Methods Med Res (2008) 1.03
Prior information in behavioral capture-recapture methods: demographic influences on drug injectors' propensity to be listed in data sources and their drug-related mortality. Am J Epidemiol (2005) 1.03
Dose selection in seamless phase II/III clinical trials based on efficacy and safety. Stat Med (2009) 0.97
Event-biased referral can distort estimation of hepatitis C virus progression rate to cirrhosis, and of prognostic influences. J Clin Epidemiol (2007) 0.94
Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review. Cochrane Database Syst Rev (2012) 0.91
Recipients of blood or blood products "at vCJD risk". BMJ (2004) 0.89
Topiramate add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev (2008) 0.88
Statistical issues in the assessment of the evidence for an interaction between factors in epilepsy trials. Stat Med (2002) 0.88
Regional variation in survival of people with cerebral palsy in the United Kingdom. Pediatrics (2005) 0.87
Multiple birth and cerebral palsy in Europe: a multicenter study. Acta Obstet Gynecol Scand (2004) 0.82
Sudden rise in uptake of hepatitis B vaccination among injecting drug users associated with a universal vaccine programme in prisons. Vaccine (2004) 0.82
Modelling the rate of change in a longitudinal study with missing data, adjusting for contact attempts. Stat Med (2011) 0.81
The benefits and harms of breast cancer screening. Lancet (2013) 0.81
Like-with-like comparisons? Lancet (2010) 0.81
The adverse effects profile of levetiracetam in epilepsy: a more detailed look. Int J Neurosci (2013) 0.81
Counting the dead: properly and promptly. Lancet (2013) 0.80
Gabapentin add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev (2013) 0.79
A statistical perspective on the design of drug-court studies. Eval Rev (2009) 0.79
Vigabatrin for refractory partial epilepsy. Cochrane Database Syst Rev (2013) 0.79
Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: increased risk following diagnosis with hepatitis C infection. Int J Drug Policy (2010) 0.79
The influence of gestational age on severity of impairment in spastic cerebral palsy. J Pediatr (2008) 0.79
Topiramate add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev (2014) 0.78
Hospitalization of hepatitis C-diagnosed individuals in Scotland for decompensated cirrhosis: a population-based record-linkage study. Eur J Gastroenterol Hepatol (2010) 0.78
Analyse transplant outcomes in distinct epochs of follow-up. Lancet (2006) 0.77
Vigabatrin for refractory partial epilepsy. Cochrane Database Syst Rev (2008) 0.77
Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods. Stat Med (2012) 0.77
Drugs and harm to society. Lancet (2011) 0.76
Review of models used to predict the future numbers of individuals with severe hepatitis C disease: therapeutic and cost implications. Expert Rev Pharmacoecon Outcomes Res (2006) 0.76
New statistical method for analyzing time to first seizure: example using data comparing carbamazepine and valproate monotherapy. Epilepsia (2007) 0.76
Tiagabine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev (2012) 0.76
Modeling the initiation of others into injection drug use, using data from 2,500 injectors surveyed in Scotland during 2008-2009. Am J Epidemiol (2015) 0.76
Community treatments for heroin and crack cocaine addiction. Lancet (2010) 0.75
Tiagabine add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev (2014) 0.75
Suicide in recently released prisoners. Lancet (2006) 0.75
Being sanguine about study design and multiple imputation. BMJ (2012) 0.75
Febrile convulsions after seasonal influenza immunisation in UK. Lancet (2011) 0.75
Performance monitoring should take costs to heart. BMJ (2004) 0.75
NICE judgment: good law risks bad science. Lancet Neurol (2007) 0.75
A comparison of customized and population-based birth-weight standards: the influence of gestational age. Eur J Obstet Gynecol Reprod Biol (2009) 0.75
Re-weighted inference about hepatitis C virus-infected communities when analysing diagnosed patients referred to liver clinics. Stat Methods Med Res (2008) 0.75
Exploring methods to investigate sentencing decisions. Eval Rev (2010) 0.75
Deprivation and stillbirth risk in rural and urban areas. Paediatr Perinat Epidemiol (2002) 0.75
Changes in rates of violent child deaths in England and Wales between 1974 and 2008: an analysis of national mortality data. Arch Dis Child (2011) 0.75
Open label extension studies and patient selection biases. J Eval Clin Pract (2008) 0.75